ODAC 30% Off Registration, Use Code: JDD30
Skip to main content
JDD HighlightsJDD WebinarsThe Latest

New Solutions for Moderate to Severe Dandruff from VICHY DERCOS

JDD Multimedia

New Solutions for Moderate to Severe Dandruff from VICHY DERCOS, the #1 dermatologist-recommended anti-dandruff brand in Europe

Living with dandruff can be uncomfortable and frustrating for the 52 million Americans who have the condition. Join Dandruff affects 52 million Americans. Join Dr. Houshmand’s review of clinical data from VICHY DERCOS, a French pharmacy brand with 40 years of global expertise in scalp and hair health. Discover the new range of shampoos, conditioners, and scalp serums, specifically formulated for US patients and combining Vichy’s renowned hair and scalp expertise with powerful anti-dandruff efficacy

Faculty


Elizabeth Bahar Houshmand, MD

Watch On Demand

cAMPfire Stories: Two Old Friends, One New Pathway, and the Future of Vitiligo

| Featured Articles, Featured Podcast, Global Steroidal Stewardship, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Jon Zippin  What happens when two longtime friends, dermatologists, and self-proclaimed science nerds get together to talk about pigment? Well, this one time, at band cAMP…. Anyway, in…

APP-solutely Essential: Putting Corticosteroid Stewardship Into Practice

| Featured Articles, Featured Podcast, Global Steroidal Stewardship, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Douglas DiRuggiero  Corticosteroids remain one of dermatology’s most reliable workhorses, but good stewardship isn’t about putting the horse out to pasture. It’s about knowing when to ride, when to…

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

| Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…

Leave a Reply